Study

Anatomy of a Runner

8,792 documented runner years across 3,129 stocks between 1963 and 2025. This page shows what those runs have in common instead of celebrating individual winners. Every value is a median from the stored price archive, no selection and no estimate.

The typical run in median values

The median is more honest than the average: a single multi-bagger does not move it. This is the middle of every documented run.

Peak return in the year

+160%

Yearly return

+67%

Largest setback during the run

-43%

ADR over 20 days

+4.9%

Base length before the breakout

85

trading days

Base depth

-35%

Volume on the breakout day

3.9x

Prior run before the base

+25%

Runs per decade

The distribution follows market history: more liquid stocks and more data mean more documented runs. The median peak column shows whether a decade's runs were also larger.

DecadeRunner yearsStocksMedian peak
1960er32+131%
1970er87+126%
1980er9575+125%
1990er696385+149%
2000er1,9911,115+157%
2010er1,7531,047+141%
2020er4,2462,489+179%

What triggered the runs

Evidenced catalysts from news, earnings dates and official SEC filings in the window around the breakout. Runs without an evidenced catalyst are deliberately not included here.

Earnings/Guidance2,592
Unternehmensmeldung791
Auftrag/Partnerschaft350
Relative Staerke/Technik326
Analysten/Re-Rating180
FDA/Clinical175
Management163
Energie/Commodity93

Stocks with multiple runner years

2,062 stocks have more than one documented runner year. Repetition is the most interesting pattern in the archive: the same names return across decades, usually with a new product cycle.

SymbolRunner yearsSpanBest peak
AMD201980 bis 2025+571%
MU161986 bis 2025+355%
CRUS141990 bis 2019+419%
SRPT142000 bis 2022+1199%
IDCC131986 bis 2025+1691%
AMSC121998 bis 2025+455%
CDE121987 bis 2025+824%
CLF122003 bis 2025+732%
FCEL122000 bis 2021+1131%
GERN121998 bis 2024+1045%
HL121980 bis 2025+497%
HOV122001 bis 2023+867%

Historical review of completed runs. Not investment advice and no statement about future price development.

Back to the runner list